Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 31, 2023

SELL
$191.51 - $216.16 $75,837 - $85,599
-396 Reduced 2.73%
14,088 $2.99 Million
Q2 2023

Jul 28, 2023

BUY
$187.64 - $206.25 $1.32 Million - $1.45 Million
7,013 Added 93.87%
14,484 $2.79 Million
Q1 2023

May 04, 2023

BUY
$127.59 - $203.08 $15,565 - $24,775
122 Added 1.66%
7,471 $1.51 Million
Q4 2022

Feb 08, 2023

SELL
$117.37 - $139.17 $2,112 - $2,505
-18 Reduced 0.24%
7,349 $944,000
Q3 2022

Oct 27, 2022

SELL
$135.27 - $180.11 $33,005 - $43,946
-244 Reduced 3.21%
7,367 $1.01 Million
Q2 2022

Jul 27, 2022

SELL
$108.81 - $179.33 $20,021 - $32,996
-184 Reduced 2.36%
7,611 $1.35 Million
Q1 2022

Apr 21, 2022

SELL
$119.61 - $157.85 $4,664 - $6,156
-39 Reduced 0.5%
7,795 $1.12 Million
Q4 2021

Jan 19, 2022

SELL
$142.57 - $190.86 $70,572 - $94,475
-495 Reduced 5.94%
7,834 $1.21 Million
Q3 2021

Oct 15, 2021

SELL
$142.45 - $169.82 $22,507 - $26,831
-158 Reduced 1.86%
8,329 $1.41 Million
Q2 2021

Aug 06, 2021

BUY
$135.08 - $161.1 $99,283 - $118,408
735 Added 9.48%
8,487 $1.34 Million
Q1 2021

May 04, 2021

BUY
$137.51 - $190.8 $329,473 - $457,156
2,396 Added 44.73%
7,752 $1.08 Million
Q4 2020

Feb 16, 2021

BUY
$164.63 - $211.93 $881,758 - $1.14 Million
5,356 New
5,356 $938,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Elite Wealth Management, Inc. Portfolio

Follow Elite Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elite Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Elite Wealth Management, Inc. with notifications on news.